Administration of elranatamab in the real-world: Treatement patterns, healthcare resource utilization, costs, effectiveness, and safety (ALTITUDE)

10/09/2024
30/10/2025
EU PAS number:
EUPAS1000000229
Study
Planned
Documents
Study protocol
Initial protocol
English (1.13 MB - PDF) View document
Updated protocol
English (1.15 MB - PDF) View document
Study results
Study report
Other information